Publications by authors named "Mark Parrino"

Claim this Profile
A
Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders.
S Geoff Severtson, Marie C Gurrola, Mark W Parrino, Matthew S Ellis, Theodore J Cicero

J Opioid Manag· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Tapentadol API Abuse Liability With the Researched Abuse, Diversion and Addiction-Related Surveillance System.
Suzanne K Vosburg, S Geoffrey Severtson, Richard C Dart, Theodore J Cicero, Steven P Kurtz, Mark W Parrino

J Pain· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Prescription drug monitoring program utilization among 15 US opioid treatment programs" [J. Subst. Abus. Treat. 85 (2018) 17-20].
Harlan Matusow, Andrew Rosenblum, Mark Parrino

J Subst Abuse Treat· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription drug monitoring program utilization among 15 US opioid treatment programs.
Harlan Matusow, Andrew Rosenblum, Mark Parrino

J Subst Abuse Treat· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Impediments to OTP Expansion in the United States and Abroad.
Mark W Parrino

Subst Use Misuse· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
Stevan Geoffrey Severtson, Matthew S Ellis, Steven P Kurtz, Andrew Rosenblum, Theodore J Cicero, Mark W Parrino

Drug Alcohol Depend· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
Mark W Parrino, Angelo Giovanni Icro Maremmani, Paul N Samuels, Icro Maremmani

J Addict Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in opioid analgesic abuse and mortality in the United States.
Richard C Dart, Hilary L Surratt, Theodore J Cicero, Mark W Parrino, S Geoff Severtson

N Engl J Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distance traveled and cross-state commuting to opioid treatment programs in the United States.
Andrew Rosenblum, Charles M Cleland, Chunki Fong, Deborah J Kayman, Barbara Tempalski, Mark Parrino

J Environ Public Health· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol education provided to opioid treatment program patients: results of a nationwide survey.
Shiela M Strauss, Gavin Harris, Carina Katigbak, David M Rindskopf, Sheena Singh, Mark W Parrino

J Drug Educ· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of self-reported misuse of prescription opioid analgesics.
Meredith Smith, Andrew Rosenblum, Mark Parrino, Chunki Fong, Salvatore Colucci

Subst Use Misuse· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation among state-level approaches to addressing alcohol abuse in opioid treatment programs.
Gavin H Harris, Shiela M Strauss, Carina Katigbak, Bhupinder S Brar, Lawrence S Brown, Mark W Parrino

J Subst Abuse Treat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-marketing surveillance of methadone and buprenorphine in the United States.
Nabarun Dasgupta, Elise J Bailey, Theodore Cicero, James Inciardi, Mark Parrino

Pain Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "black box" of prescription drug diversion.
James A Inciardi, Hilary L Surratt, Theodore J Cicero, Steven P Kurtz, Steven S Martin, Mark W Parrino

J Addict Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.
Michael F Schneider, J Elise Bailey, Theodore J Cicero, Richard C Dart, James A Inciardi, Mark Parrino

Pharmacoepidemiol Drug Saf· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescription opioid abuse among enrollees into methadone maintenance treatment.
Andrew Rosenblum, Mark Parrino, Sidney H Schnoll, Chunki Fong, Carleen Maxwell

Drug Alcohol Depend· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A commentary on "Urine testing in methadone maintenance treatment: applications and limitations".
Mark W Parrino

J Subst Abuse Treat· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis